“…Similarly in human post-mortem AD samples, we identified key differentially-expressed genes such as GFAP (log2 FC 1.48, p < 0.0001), SERPING1 (log2 FC 1.02, p < 0.05), KRT5 (log2 FC -3.52, p < 0.0001), and NEUROD6 (log2 FC -1.23, p < 0.05), all genes that have been reported to be altered in AD 38 (Supplementary Table S2 ). We also identified differentially-expressed miRNA that had previously been discovered in APP/PS1 mice 39 , 40 (miR-26a-5p, log2 FC 0.58, p < 0.05; miR-7b-5p, log2 FC -0.55, p < 0.05; Supplementary Table S3 ) and human AD patients 41 , 42 (miR-129-5p, log2 FC -1.14, p < 0.05; miR-151b, log2 FC -1.28, p < 0.05; Supplementary Table S4 ). As is often recommended for RNA-Seq experiments, further investigation and validation of differentially-expressed transcripts by, for example, quantitative RT-PCR would address concerns with regards to quantification.…”